Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 73
- +5 vs. Q4 2025
- Portfolio value
- $175.7M
- +$4.87M (+2.8%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KLACKLA Corp | COM NEW | 19,883 | $29.3M | 16.7% | −2,000−9.1% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 306,268 | $18.6M | 10.6% | +3,426+1.1% | Added | History |
| CMPXCompass Therapeutics, Inc. | COM | 1,465,867 | $7.75M | 4.4% | −127,071−8.0% | Reduced | History |
| LRCXLam Research Corp | Stock | 36,000 | $7.69M | 4.4% | −4,329−10.7% | Reduced | History |
| STOKStoke Therapeutics, Inc. | COM | 210,000 | $6.84M | 3.9% | −50,000−19.2% | Reduced | History |
| OVVOvintiv Inc. | COM | 107,500 | $6.38M | 3.6% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 445,400 | $5.71M | 3.3% | +130,000+41.2% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 100,000 | $4.82M | 2.7% | +10,000+11.1% | Added | History |
| SLDBSolid Biosciences Inc. | COM NEW | 625,980 | $4.51M | 2.6% | −79,975−11.3% | Reduced | History |
| PRTAProthena Corp Public Ltd Co | SHS | 449,019 | $4.36M | 2.5% | +8,000+1.8% | Added | History |
| BDSXBiodesix Inc | COM | 286,804 | $4.16M | 2.4% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 171,000 | $3.81M | 2.2% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 35,000 | $3.69M | 2.1% | −20,000−36.4% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 27,190 | $3.58M | 2.0% | 00.0% | Unchanged | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 219,000 | $3.27M | 1.9% | −50,000−18.6% | Reduced | History |
| RLMDRelmada Therapeutics, Inc. | COM | 409,387 | $2.85M | 1.6% | +409,387 | New | History |
| OCULOcular Therapeutix, Inc | COM | 320,000 | $2.71M | 1.5% | +320,000 | New | History |
| UTHRUnited Therapeutics Corp | COM | 4,500 | $2.67M | 1.5% | +1,500+50.0% | Added | History |
| NKTRNektar Therapeutics | COM NEW | 31,000 | $2.23M | 1.3% | 00.0% | Unchanged | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 70,095 | $2.22M | 1.3% | +70,095 | New | History |
| NVCRNovoCure Ltd | ORD SHS | 202,330 | $2.21M | 1.3% | +50,230+33.0% | Added | History |
| EQTEQT Corp | Stock | 34,619 | $2.20M | 1.3% | 00.0% | Unchanged | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 195,000 | $2.17M | 1.2% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 463,599 | $2.15M | 1.2% | +899+0.2% | Added | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 375,000 | $2.07M | 1.2% | +375,000 | New | History |
| PACBPacific Biosciences of California, Inc. | COM | 1,500,000 | $1.98M | 1.1% | +1,000,000+200.0% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 30,000 | $1.98M | 1.1% | 00.0% | Unchanged | History |
| CORTCorcept Therapeutics Inc | COM | 47,200 | $1.90M | 1.1% | −20,000−29.8% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 44,000 | $1.77M | 1.0% | 00.0% | Unchanged | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.77M | 1.0% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 250,000 | $1.70M | 1.0% | +250,000 | New | History |
| QUREuniQure N.V. | SHS | 100,697 | $1.65M | 0.9% | +69,908+227.1% | Added | History |
| ZBIOZenas BioPharma, Inc. | COM | 70,000 | $1.37M | 0.8% | +70,000 | New | History |
| QDELQuidelOrtho Corp | COM | 82,548 | $1.36M | 0.8% | +10,000+13.8% | Added | History |
| FHTXFoghorn Therapeutics Inc. | COM | 281,730 | $1.35M | 0.8% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 62,000 | $1.30M | 0.7% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 21,000 | $1.22M | 0.7% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 57,000 | $1.15M | 0.7% | 00.0% | Unchanged | History |
| IMNMImmunome Inc. | COM | 50,000 | $1.09M | 0.6% | −80,000−61.5% | Reduced | History |
| FCXFreeport-McMoran Inc | Stock | 18,040 | $1.06M | 0.6% | −60.0% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 6,000 | $1.01M | 0.6% | −61−1.0% | Reduced | History |
| BIIBBiogen Inc. | COM | 5,000 | $916.6K | 0.5% | +5,000 | New | History |
| LPCNLipocine Inc. | COM NEW | 111,786 | $893.2K | 0.5% | +111,786 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 29,200 | $867.5K | 0.5% | −13,800−32.1% | Reduced | History |
| HROWHarrow, Inc. | COM | 24,000 | $846.2K | 0.5% | −10,000−29.4% | Reduced | History |
| PHVSPharvaris N.V. | COM | 29,847 | $843.2K | 0.5% | 00.0% | Unchanged | History |
| VSTMVerastem, Inc. | COM NEW | 150,000 | $795.0K | 0.5% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 9,000 | $757.5K | 0.4% | −7,000−43.8% | Reduced | History |
| HALOHalozyme Therapeutics, Inc. | COM | 10,100 | $652.8K | 0.4% | 00.0% | Unchanged | History |
| BBIOBridgeBio Pharma, Inc. | COM | 8,688 | $645.2K | 0.4% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 14,000 | $563.2K | 0.3% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 16,860 | $561.8K | 0.3% | +16,860 | New | History |
| RCUSArcus Biosciences, Inc. | COM | 25,889 | $559.2K | 0.3% | +25,889 | New | History |
| RGNXREGENXBIO Inc. | COM | 66,270 | $555.3K | 0.3% | +66,270 | New | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 83,952 | $467.6K | 0.3% | +83,952 | New | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 127,025 | $454.8K | 0.3% | +127,025 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 20,100 | $393.2K | 0.2% | +20,100 | New | History |
| OMOutset Medical, Inc. | COM | 98,882 | $379.7K | 0.2% | −310.0% | Reduced | History |
| LUNGPulmonx Corp | COM | 250,221 | $322.8K | 0.2% | −352−0.1% | Reduced | History |
| CSTLCastle Biosciences Inc | COM | 12,900 | $316.7K | 0.2% | −67,700−84.0% | Reduced | History |
| TRINTrinity Capital Inc. | COM | 20,000 | $294.2K | 0.2% | 00.0% | Unchanged | History |
| CADLCandel Therapeutics, Inc. | COM | 60,000 | $294.0K | 0.2% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 74,918 | $289.2K | 0.2% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 20,000 | $284.2K | 0.2% | 00.0% | Unchanged | History |
| KBDCKayne Anderson BDC, Inc. | COM SHS | 20,000 | $274.4K | 0.2% | 00.0% | Unchanged | History |
| GRCEGrace Therapeutics, Inc. | CL A | 50,000 | $231.5K | 0.1% | +50,000 | New | History |
| ELUTElutia Inc. | CL A COM | 165,094 | $173.3K | 0.1% | −97,924−37.2% | Reduced | History |
| KYNBKyntra Bio, Inc. | COM NEW | 22,566 | $153.0K | 0.1% | +22,566 | New | History |
| QNRXQuoin Pharmaceuticals Ltd. | ADR | 20,000 | $132.0K | 0.1% | +20,000 | New | History |
| PHRPhreesia, Inc. | COM | 14,300 | $119.8K | 0.1% | −96,400−87.1% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 17,503 | $41.0K | <0.1% | +503+3.0% | Added | History |
| DCGODocGo Inc. | COM | 39,573 | $24.9K | <0.1% | −10,335−20.7% | Reduced | History |
| GOSSGossamer Bio, Inc. | COM | 18,176 | $5.97K | <0.1% | −120,000−86.8% | Reduced | History |
Sold out since Q4 2025 (12)
Positions held at the end of Q4 2025 that are gone from this filing.
| Security | Class | Shares in Q4 2025 | Value in Q4 2025 | % of portfolio in Q4 2025 | History |
|---|---|---|---|---|---|
| FOLDAmicus Therapeutics, Inc. | COM | 253,000 | $3.60M | 2.1% | History |
| MASIMasimo Corp | COM | 8,280 | $1.08M | 0.6% | History |
| TXG10x Genomics, Inc. | CL A COM | 59,000 | $962.3K | 0.6% | History |
| VTYXVentyx Biosciences, Inc. | COM | 100,827 | $910.5K | 0.5% | History |
| ILMNIllumina, Inc. | COM | 6,000 | $787.0K | 0.5% | History |
| BHVNBiohaven Ltd. | COM | 59,365 | $670.2K | 0.4% | History |
| TMCITreace Medical Concepts, Inc. | COM | 226,947 | $556.0K | 0.3% | History |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 15,000 | $508.1K | 0.3% | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 18,058 | $379.9K | 0.2% | History |
| LQDALiquidia Corp | COM NEW | 10,000 | $344.9K | 0.2% | History |
| INBXInhibrx Biosciences, Inc. | COM | 3,698 | $292.1K | 0.2% | History |
| ALMSAlumis Inc. | COM | 10,000 | $97.6K | 0.1% | History |